Literature DB >> 3279421

Transforming genes in chronic myelogenous leukemia.

E Liu1, B Hjelle, J M Bishop.   

Abstract

Chronic myelogenous leukemia (CML) is a hematopoietic malignancy characterized by an indolent chronic phase that invariably leads to a "blast crisis" indistinguishable from acute leukemia. Using a sensitive assay based on gene transfer and tumorigenesis, we sought evidence that damage to protooncogenes might figure in the progression from the chronic to the blast phase of CML. Seven of the 12 patients with CML examined in this manner harbored transforming genes. Mutations in RAS protooncogenes were detected in the leukemic cells from 1 of 6 chronic-phase patients, and 3 of 6 blast-crisis patients. In addition, a presently unidentified transforming gene (neither RAS nor RAF) was detected in 1 patient with chronic phase and 1 with blast crisis. Our data indicate that mutations in RAS genes may play diverse roles in the pathogenesis of CML.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279421      PMCID: PMC279899          DOI: 10.1073/pnas.85.6.1952

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

Review 1.  Ph1-positive leukaemia, including chronic myelogenous leukaemia.

Authors:  J D Rowley
Journal:  Clin Haematol       Date:  1980-02

2.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

3.  Activation of a novel human transforming gene, ret, by DNA rearrangement.

Authors:  M Takahashi; J Ritz; G M Cooper
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

4.  New human transforming genes detected by a tumorigenicity assay.

Authors:  O Fasano; D Birnbaum; L Edlund; J Fogh; M Wigler
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

5.  Mutations of the Kirsten-ras proto-oncogene in human preleukaemia.

Authors:  E Liu; B Hjelle; R Morgan; F Hecht; J M Bishop
Journal:  Nature       Date:  1987 Nov 12-18       Impact factor: 49.962

6.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.

Authors:  J L Bos; D Toksoz; C J Marshall; M Verlaan-de Vries; G H Veeneman; A J van der Eb; J H van Boom; J W Janssen; A C Steenvoorden
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

7.  Three different mutations in codon 61 of the human N-ras gene detected by synthetic oligonucleotide hybridization.

Authors:  J L Bos; M Verlaan-de Vries; A M Jansen; G H Veeneman; J H van Boom; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1984-12-11       Impact factor: 16.971

8.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

9.  Transforming genes in human leukemia cells.

Authors:  H Hirai; S Tanaka; M Azuma; Y Anraku; Y Kobayashi; M Fujisawa; T Okabe; A Urabe; F Takaku
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

10.  Mutation affecting the 12th amino acid of the c-Ha-ras oncogene product occurs infrequently in human cancer.

Authors:  A P Feinberg; B Vogelstein; M J Droller; S B Baylin; B D Nelkin
Journal:  Science       Date:  1983-06-10       Impact factor: 47.728

View more
  40 in total

1.  The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.

Authors:  H Ahuja; M Bar-Eli; Z Arlin; S Advani; S L Allen; J Goldman; D Snyder; A Foti; M Cline
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.

Authors:  Amy K Keating; Grace K Kim; Ashley E Jones; Andrew M Donson; Kathryn Ware; Jean M Mulcahy; Dana B Salzberg; Nicholas K Foreman; Xiayuan Liang; Andrew Thorburn; Douglas K Graham
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

3.  Transforming genes and chromosome aberrations in therapy-related leukemia and myelodysplastic syndrome.

Authors:  K Inokuchi; N Amuro; M Futaki; K Dan; T Shinohara; S Kuriya; T Okazaki; T Nomura
Journal:  Ann Hematol       Date:  1991-06       Impact factor: 3.673

4.  bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation.

Authors:  A Engelman; N Rosenberg
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

Review 5.  Molecular analysis of Philadelphia chromosome positive leukaemias.

Authors:  B D Young
Journal:  Br J Cancer Suppl       Date:  1988-12

6.  The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.

Authors:  T G Lugo; O N Witte
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

7.  Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors.

Authors:  Alexis Mollard; Steven L Warner; Lee T Call; Mark L Wade; Jared J Bearss; Anupam Verma; Sunil Sharma; Hariprasad Vankayalapati; David J Bearss
Journal:  ACS Med Chem Lett       Date:  2011-12-08       Impact factor: 4.345

8.  Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.

Authors:  J C Young; O N Witte
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

9.  ERK2, but not ERK1, mediates acquired and "de novo" resistance to imatinib mesylate: implication for CML therapy.

Authors:  Clara I Aceves-Luquero; Anupriya Agarwal; Juan L Callejas-Valera; Laura Arias-González; Azucena Esparís-Ogando; Luis del Peso Ovalle; Itxaso Bellón-Echeverria; Miguel A de la Cruz-Morcillo; Eva M Galán Moya; Inmaculada Moreno Gimeno; Juan C Gómez; Michael W Deininger; Atanasio Pandiella; Ricardo Sánchez Prieto
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

10.  axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.

Authors:  J P O'Bryan; R A Frye; P C Cogswell; A Neubauer; B Kitch; C Prokop; R Espinosa; M M Le Beau; H S Earp; E T Liu
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.